Humulin 70/30

Humulin 70/30

Manufacturer:

Eli Lilly

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Per 100 IU/mL Human insulin isophane 70%, human insulin 30% (recombinant DNA origin)
Indications/Uses
Treatment of patients w/ DM who require insulin for the maintenance of glucose homeostasis.
Dosage/Direction for Use
Administration
Should be taken with food: Administer w/in 30 min before meals.
Contraindications
Hypersensitivity. Hypoglycaemia. Do not administer via IV.
Special Precautions
Transferring from another type or brand of insulin or switching from animal insulin to human insulin. Conditions which may make the early warning symptoms of hypoglycaemia less pronounced including long-duration diabetes, diabetic nerve disease or medications eg, β-blockers. Formation of Ab. Patient w/ diseases of adrenal, pituitary, or thyroid glands; renal or hepatic impairment; illness or emotional disturbances; changes in level of physical activity or usual diet. Perform continuous rotation of inj site to reduce risk of developing lipodystrophy & cutaneous amyloidosis. Observe for signs & symptoms of heart failure, wt gain & oedema if therapy is in combination w/ pioglitazone, especially in patients w/ risk factors for development of cardiac heart failure. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Hypoglycaemia, local allergy (redness, swelling & itching at the site of insulin inj); oedema. Systemic allergy, lipodystrophy.
Drug Interactions
Insulin requirements may be increased by substances w/ hyperglycaemic activity eg, glucocorticoids, thyroid hormones, growth hormone, danazol, β2-sympathomimetics (eg, ritodrine, salbutamol, terbutaline), thiazides. Insulin requirements may be reduced by drugs w/ hypoglycaemic activity eg, oral hypoglycaemics, salicylates (eg, ASA), certain antidepressants (MAOIs), certain ACEIs (captopril, enalapril), angiotensin II receptor blockers, non-selective β-blocking agents & alcohol. Somatostatin analogues (octreotide, lanreotide) may both decrease or increase insulin dose requirements.
MIMS Class
Insulin Preparations
ATC Classification
A10AD01 - insulin (human) ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Humulin 70/30 susp for inj 100 IU/mL
Packing/Price
(cartridge) 3 mL x 5 × 1's; (vial) 10 mL x 1's
/hongkong/image/info/humulin 70-30 susp for inj 100 iu-ml/100 iu-ml x 10 ml?id=c1fc19e7-6697-420a-99e9-9fab010a4af6
/hongkong/image/info/humulin 70-30 susp for inj 100 iu-ml/100 iu-ml x 3 ml?id=19e9e354-b912-449a-a2af-9fab0109ad54
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in